CTOs on the Move

Osseon Therapeutics

www.osseon.com

 
Osseon Therapeutics is a Santa Rosa, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.osseon.com
  • 2330 Circadian Way
    Santa Rosa, CA USA 95407
  • Phone: 707.636.5940

Executives

Name Title Contact Details

Similar Companies

Technology and Patent Research International

Technology and Patent Research International, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clipper America Inc

Clipper America Inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Salient Surgical Technologies

Salient Surgical Technologies, Inc. is a Portsmouth, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedCare Investment Funds

MedCare and its affiliated entities manage approximately $1 billion in assets, the substantial majority of which are related to the medical and healthcare services industry.

RRD International, LLC

Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).